Ci Chu is Chief Discovery Officer and Co-Founder at Xaira Therapeutics, where she leads AI-enabled drug discovery. She previously held senior research and genomics roles at insitro, Verily Life Sciences and X, the moonshot factory, following her early research career at the Genome Institute of Singapore. She holds a Ph.D. in Cancer Biology from Stanford University and a B.S. in Chemistry and Biology from Duke University.

